v3.21.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 21,531,665 $ 17,958,989
Other receivable from joint venture 0 400,000
Prepaid expenses and other current assets 172,460 47,371
Total Current Assets 21,704,125 18,406,360
Other Assets    
Patents and trademarks, net 85,562 1,144,888
Total Assets 21,789,687 19,551,248
Current Liabilities    
Accounts payable and accrued liabilities 382,130 350,299
Accrued legal settlement costs 4,200,000 0
Total Current Liabilities 4,582,130 350,299
Commitments and contingencies - Note 7 0 0
Stockholders' Equity    
Preferred stock, $0.001 par value, 10,000,000 authorized shares 0 0
Common stock, $0.001 par value, 8,333,333 authorized, 6,567,110 shares and 3,252,371 shares issued and outstanding at December 31, 2020 and 2019, respectively 6,567 3,252
Additional paid-in capital 146,353,232 133,932,615
Accumulated deficit (129,155,608) (114,738,342)
Total Stockholders' Equity 17,207,557 19,200,949
Total Liabilities and Stockholders' Equity 21,789,687 19,551,248
Convertible Series A Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock, $0.001 par value, 10,000,000 authorized shares 699 757
Convertible Series B Preferred Stock [Member]    
Stockholders' Equity    
Preferred stock, $0.001 par value, 10,000,000 authorized shares $ 2,667 $ 2,667

Source